Evidence map›Paper›PMID 30591932›Full record

ReviewGenes & diseases2018

A critical role of the thioredoxin domain containing protein 5 (TXNDC5) in redox homeostasis and cancer development.

Hedy A Chawsheen, Qi Ying, Hong Jiang, Qiou Wei

Open access · diamondAbstract readReview
In one paragraph

Review in Genes & diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?Current issues in molecular biology · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. The role and mechanism of TXNDC5 in diseases.European journal of medical research · 2022
    Review
  19. Circular RNAs in hepatocellular carcinoma: Recent advances.World journal of gastrointestinal oncology · 2022
    Review
  20. Inhibition of TXNDC5 attenuates lipopolysaccharide-induced septic shock by altering inflammatory responses.Laboratory investigation; a journal of technical methods and pathology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hedy A ChawsheenDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Qi YingDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Hong JiangDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Qiou WeiDepartment of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
University of Kentucky · US

Funding

Role of Sulfiredoxin in Colorectal Cancer DevelopmentR01CA222596 · NCI · UNIVERSITY OF KENTUCKY · PI WEI, QIOU · 2018 to 2022
$1.7M
NCI NIH HHS R01 CA222596
6 · The paper itself

Abstract

Correct folding of nascent peptides occurs in the endoplasmic reticulum (ER). It is a complicate process primarily accomplished by the coordination of multiple redox proteins including members of the protein disulfide isomerase (PDI) family. As a critical member of the PDI family, thioredoxin domain containing protein 5 (TXNDC5) assists the folding of newly synthesized peptides to their mature form through series of disulfide bond exchange reactions. Interestingly, TXNDC5 is frequently found overexpressed in specimens of many human diseases including various types of cancer. In this review, we summarized the biochemical function of TXNDC5 in mammalian cells and the recent progress on the understanding of its role and molecular mechanisms in cancer development. Findings of TXNDC5 in the activation of intracellular signaling pathways, stimulation of cell growth & proliferation, facilitation of cell survival and modulation of extracellular matrix to affect cancer cell invasion and metastasis are reviewed. These published studies suggest that strategies of targeting TXNDC5 can be developed as potentially valuable methods for the treatment of certain types of cancer in patients.

Indexed as

CancerCell signalProtein disulfide isomeraseProtein foldingReceptor modulation

Identifiers

PMID30591932
PMCPMC6303481
OpenAlexW2894370306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.